Skip to content

Public FDA record

Z-0028-2018: Xpert EV Assay, Catalog GXEV-100N-10. The Cepheid Xpert EV assay is a reverse transcription polymerase c

Recall record Z-0028-2018 for Cepheid. View source facts, labeled dates, and the original FDA record.

FDA identifier
Z-0028-2018
Company in FDA record
Cepheid
FDA record creation date
Oct 18, 2017
First observed by MedTech Watch
Nov 16, 2026
Latest observed content change
Nov 16, 2026
Recall classification
Class II

Reason stated in the source

Customers have reported a higher than expected number of invalid test results when using the recalled product per the package insert.

Source facts

Action
Recall notification letters were sent out to affected consignees on 9/15/17.
Initiated
2017-09-15
Root cause
Nonconforming Material/Component
Terminated
2023-07-28
Distribution
USA, Austria, Australia, Belgium, Brazil, Canada, Chile, Colombia, Germany, Spain, France, UK, Ireland, Israel, Italy, South Korea, Lebanon, Netherlands, Philippines, Saudi Arabia, Sweden, Uruguay
Recall number
Z-0028-2018
Recall status
Terminated
CDRH record ID
158837
FDA record created
2017-10-18
Recall event number
78177

Source facts and excerpts are reproduced for research. Dates retain their source meanings. “First observed” describes collection, not FDA publication or product launch.

Recall classification is supplied only when the recall number matches an enforcement record. Recall class and device class are different fields. Several recall records may belong to one recall event.

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗